Companies › CAMP

CAMP4 THERAPEUTICS CORP (CAMP)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001736730 · EDGAR filings · Updated 2026-07-27

CAMP4 THERAPEUTICS CORP (CAMP) has reported institutional ownership of 76.6%, with 46 institutional managers holding positions valued at $175.5M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Filings this week (1)

• 2026-07-27 — Current report (8-K) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-06-12 — Insider transaction reported (Form 4)
• 2026-06-12 — Insider transaction reported (Form 4)
• 2026-06-12 — Insider transaction reported (Form 4)
• 2026-06-12 — Insider transaction reported (Form 4)
• 2026-06-12 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, CAMP4 THERAPEUTICS CORP has 46 institutional holders and institutional ownership of 76.6%.

Insider activity

Insiders reported 10 transactions (9 buys, 0 sells) across 9 reporting insiders, with a net reported value of $8.55M.

Data flags from SEC filings

Related companies

ANIKA THERAPEUTICS INC (ANIK) · ABEONA THERAPEUTICS INC (ABEO) · LINEAGE CELL THERAPEUTICS IN (LCTX) · ORASURE TECHNOLOGIES INC (OSUR) · PULSE BIOSCIENCES INC (PLSE) · NIAGEN BIOSCIENCE INC (NAGE)